The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
Bangladesh · Delayed Price · Currency is BDT 292.10
-1.20 (-0.41%)
At close: Nov 3, 2025
DSE:IBNSINA Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Cash & Equivalents | 314.9 | 365.23 | 232.23 | 342.61 | 281.24 | Upgrade |
Cash & Short-Term Investments | 314.9 | 365.23 | 232.23 | 342.61 | 281.24 | Upgrade |
Cash Growth | -13.78% | 57.27% | -32.22% | 21.82% | 40.68% | Upgrade |
Accounts Receivable | 196.05 | 195.83 | 96.1 | 43.61 | 23.61 | Upgrade |
Other Receivables | - | 6.69 | 11.03 | 10.22 | 3.66 | Upgrade |
Receivables | 196.05 | 202.51 | 107.13 | 53.83 | 27.27 | Upgrade |
Inventory | 1,808 | 1,585 | 1,157 | 1,008 | 782.16 | Upgrade |
Other Current Assets | 526.21 | 467.23 | 340.44 | 232.54 | 367.16 | Upgrade |
Total Current Assets | 2,845 | 2,620 | 1,836 | 1,637 | 1,458 | Upgrade |
Property, Plant & Equipment | 4,621 | 3,826 | 3,103 | 2,596 | 2,331 | Upgrade |
Long-Term Investments | - | 50.17 | 57.22 | 56.11 | 56.87 | Upgrade |
Other Long-Term Assets | 80.37 | 13.05 | 8.8 | 21.66 | - | Upgrade |
Total Assets | 7,547 | 6,509 | 5,006 | 4,310 | 3,845 | Upgrade |
Accounts Payable | 842.29 | 260.3 | 282.31 | 166.18 | 231.65 | Upgrade |
Accrued Expenses | - | 249.51 | 218.04 | 97.59 | 137.68 | Upgrade |
Short-Term Debt | 953.68 | 1,243 | 512.14 | 534.29 | 377.5 | Upgrade |
Current Portion of Long-Term Debt | 119.45 | 62.3 | 72.21 | 70.18 | 65.16 | Upgrade |
Current Portion of Leases | 23.8 | 25.54 | 22.41 | 22.06 | 2.37 | Upgrade |
Current Income Taxes Payable | 495.25 | 284.58 | 212.06 | 165.56 | 279.3 | Upgrade |
Other Current Liabilities | 42.1 | 193.32 | 142.3 | 68.17 | 61.62 | Upgrade |
Total Current Liabilities | 2,477 | 2,318 | 1,461 | 1,124 | 1,155 | Upgrade |
Long-Term Debt | 974.71 | 530.49 | 330.09 | 368.01 | 419.62 | Upgrade |
Long-Term Leases | - | 24.8 | 51.34 | 74.75 | 1.99 | Upgrade |
Pension & Post-Retirement Benefits | 0.99 | 1.19 | 1.01 | 0.73 | 0.09 | Upgrade |
Long-Term Deferred Tax Liabilities | 96.46 | 101.18 | 105.81 | 117.72 | 118.87 | Upgrade |
Other Long-Term Liabilities | 0 | 0 | -0 | - | - | Upgrade |
Total Liabilities | 3,549 | 2,976 | 1,950 | 1,685 | 1,696 | Upgrade |
Common Stock | 312.44 | 312.44 | 312.44 | 312.44 | 312.44 | Upgrade |
Retained Earnings | 3,630 | 3,194 | 2,711 | 2,293 | 1,834 | Upgrade |
Comprehensive Income & Other | -15.54 | -8.61 | -2.27 | -0.69 | 0.15 | Upgrade |
Total Common Equity | 3,927 | 3,497 | 3,021 | 2,604 | 2,146 | Upgrade |
Minority Interest | 70.95 | 35.88 | 35.05 | 20.66 | 3.35 | Upgrade |
Shareholders' Equity | 3,998 | 3,533 | 3,056 | 2,625 | 2,150 | Upgrade |
Total Liabilities & Equity | 7,547 | 6,509 | 5,006 | 4,310 | 3,845 | Upgrade |
Total Debt | 2,072 | 1,886 | 988.19 | 1,069 | 866.65 | Upgrade |
Net Cash (Debt) | -1,757 | -1,495 | -723.75 | -695.57 | -580.23 | Upgrade |
Net Cash Per Share | -56.23 | -47.86 | -23.16 | -22.26 | -18.57 | Upgrade |
Filing Date Shares Outstanding | 31.24 | 31.24 | 31.24 | 31.24 | 31.24 | Upgrade |
Total Common Shares Outstanding | 31.24 | 31.24 | 31.24 | 31.24 | 31.24 | Upgrade |
Working Capital | 368.68 | 302.22 | 374.96 | 512.52 | 302.55 | Upgrade |
Book Value Per Share | 125.69 | 111.94 | 96.68 | 83.36 | 68.69 | Upgrade |
Tangible Book Value | 3,927 | 3,497 | 3,021 | 2,604 | 2,146 | Upgrade |
Tangible Book Value Per Share | 125.69 | 111.94 | 96.68 | 83.36 | 68.69 | Upgrade |
Construction In Progress | - | 1,139 | 572.47 | 144.25 | 111.41 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.